What are the limits to biomedical research acceleration through general-purpose AI?
Faster models do not automatically mean faster science. Experiments take time, infrastructure matters, and researchers still need to assess what a result means.
Our paper in Scientific Reports brings together a scoping literature review, a framework for assessing AI capabilities across the research lifecycle, and expert elicitation with eight biomedical researchers. It examines where acceleration is plausible and what could limit it.
I co-authored the work in the Samwald Lab at the Medical University of Vienna. The question continues to shape how I think about building AI for science: which change would actually help a lab learn faster?